Total Payments
$7,916
2024 Payments
$37.26
Companies
46
Transactions
527
Medicare Patients
3,314
Medicare Billing
$227,342
Payment Breakdown by Category
Food & Beverage$7,892 (99.7%)
Education$24.01 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,892 | 523 | 99.7% |
| Education | $24.01 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,157 | 52 | $0 (2024) |
| AbbVie Inc. | $811.63 | 42 | $0 (2023) |
| Novo Nordisk Inc | $656.68 | 58 | $0 (2023) |
| PFIZER INC. | $613.47 | 55 | $0 (2024) |
| Amgen Inc. | $600.27 | 31 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $507.47 | 23 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $391.41 | 42 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $379.10 | 28 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $330.78 | 22 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $311.57 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.26 | 2 | PFIZER INC. ($20.29) |
| 2023 | $572.63 | 34 | AbbVie Inc. ($132.80) |
| 2022 | $576.29 | 34 | Novo Nordisk Inc ($154.66) |
| 2021 | $432.40 | 25 | AbbVie Inc. ($172.99) |
| 2020 | $375.36 | 29 | Allergan, Inc. ($114.25) |
| 2019 | $1,955 | 152 | Janssen Pharmaceuticals, Inc ($287.66) |
| 2018 | $1,754 | 126 | AbbVie, Inc. ($212.44) |
| 2017 | $2,214 | 125 | AstraZeneca Pharmaceuticals LP ($644.21) |
All Payment Transactions
527 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PAIN | ||||||
| 11/03/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Respiratory | ||||||
| 10/26/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Hematology | ||||||
| 10/24/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: PAIN | ||||||
| 10/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Cardio-renal | ||||||
| 09/20/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.09 | General |
| 08/29/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.64 | General |
| 08/16/2023 | AbbVie Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 07/27/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Respiratory | ||||||
| 07/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Gastroenterology | ||||||
| 07/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Gastroenterology | ||||||
| 06/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/17/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Gastroenterology | ||||||
| 04/29/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Neuroscience | ||||||
| 04/18/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Diabetes | ||||||
| 04/11/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: INSOMNIA | ||||||
| 03/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,024 | 1,464 | $179,369 | $59,791 |
| 2022 | 23 | 1,117 | 1,608 | $216,024 | $71,538 |
| 2021 | 17 | 699 | 1,076 | $152,164 | $52,222 |
| 2020 | 8 | 474 | 909 | $165,433 | $43,791 |
Total Patients
3,314
Total Services
5,057
Medicare Billing
$227,342
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 319 | $93,148 | $28,094 | 30.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $29,502 | $12,224 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 142 | $29,252 | $8,828 | 30.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 130 | 192 | $3,066 | $1,562 | 50.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 101 | 146 | $4,526 | $1,511 | 33.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 81 | 102 | $4,080 | $1,326 | 32.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $1,586 | $928.31 | 58.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 43 | 54 | $2,700 | $888.84 | 32.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 21 | $2,688 | $874.76 | 32.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 85 | 107 | $2,140 | $814.27 | 38.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 39 | 54 | $1,350 | $514.08 | 38.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $700.00 | $417.34 | 59.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 12 | 14 | $840.00 | $406.14 | 48.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 51 | 68 | $816.00 | $384.88 | 47.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 24 | 30 | $600.00 | $256.87 | 42.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 13 | 16 | $960.00 | $236.48 | 24.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 35 | 45 | $495.00 | $228.60 | 46.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 16 | $512.00 | $174.08 | 34.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $408.00 | $122.21 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 344 | $100,448 | $30,335 | 30.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 102 | 102 | $30,396 | $13,003 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 185 | $38,110 | $11,698 | 30.7% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 11 | 11 | $4,719 | $2,711 | 57.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $6,016 | $2,445 | 40.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 112 | 155 | $4,805 | $1,606 | 33.4% |
About Dr. Kamel Sadek, M.D
Dr. Kamel Sadek, M.D is a Family Medicine healthcare provider based in Avondale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144384603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kamel Sadek, M.D has received a total of $7,916 in payments from pharmaceutical and medical device companies, with $37.26 received in 2024. These payments were reported across 527 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,892).
As a Medicare-enrolled provider, Sadek has provided services to 3,314 Medicare beneficiaries, totaling 5,057 services with total Medicare billing of $227,342. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Avondale, AZ
- Active Since 12/20/2006
- Last Updated 04/23/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144384603
Products in Payments
- FARXIGA (Drug) $589.19
- BEVESPI AEROSPHERE (Drug) $382.77
- Trintellix (Drug) $329.89
- JANUVIA (Drug) $300.28
- CHANTIX (Drug) $296.85
- XARELTO (Drug) $275.40
- Ozempic (Drug) $256.28
- INVOKANA (Drug) $232.07
- VRAYLAR (Drug) $204.92
- Androgel (Drug) $199.54
- UBRELVY (Drug) $193.98
- JARDIANCE (Drug) $156.27
- GLYXAMBI (Drug) $155.00
- Prolia (Biological) $150.23
- Aimovig (Biological) $149.29
- Repatha (Biological) $146.21
- YOSPRALA (Drug) $140.80
- EVENITY (Biological) $135.77
- TOUJEO (Drug) $128.22
- Synthroid (Drug) $118.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Avondale
Dr. Wayne Geller
Family Medicine — Payments: $408,134
Family Medicine $408,134
Dr. Phat Hoang, M.d, M.D
Family Medicine — Payments: $101,512
Family Medicine $101,512
Dr. Steven Sumpter, Do, DO
Family Medicine — Payments: $7,896
Family Medicine $7,896
Shane Speirs, M.d, M.D
Family Medicine — Payments: $2,252
Family Medicine $2,252
Dr. Pamela Valka, D.o, D.O
Family Medicine — Payments: $1,024
Family Medicine $1,024
Dr. Brent Nedella, Do, Faafp, DO, FAAFP
Family Medicine — Payments: $357.00
Family Medicine $357.00